Platelet activating factor in allergies

International Journal of Immunopathology and Pharmacology

Volumn 28, Issue 4, 2015, Pages 584-589

  Pałgan, Krzysztof ^a   Bartuzi, Zbigniew ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

anaphylaxis; bronchial asthma; platelet activating factor; urticaria

Indexed keywords

ADRENALIN; EOTAXIN; HISTAMINE; INTERLEUKIN 6; LEPTIN; PROSTAGLANDIN E2; RANTES; THROMBOCYTE ACTIVATING FACTOR; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC REACTION; ANAPHYLAXIS; ANTIGEN ANTIBODY COMPLEX; ARTICLE; ASTHMA; CARDIOVASCULAR SYMPTOM; CELL ACTIVATION; COMPARATIVE STUDY; DISEASE SEVERITY; EOSINOPHIL; HUMAN; INOTROPISM; MAST CELL; MEMBRANE PERMEABILITY; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESPIRATORY EPITHELIUM; SKIN CAPILLARY; URTICARIA; PHYSIOLOGY;

ANAPHYLAXIS; ASTHMA; EOSINOPHILS; HUMANS; MAST CELLS; PLATELET ACTIVATING FACTOR; URTICARIA;

EID: 84946091783     PISSN: 03946320     EISSN: 20587384     Source Type: Journal    
DOI: 10.1177/0394632015600598     Document Type: Article

References (39)

1. Benveniste J, (1974) Platelet-activating factor, a new mediator of anaphylaxis and immune complex deposition from rabbit and human basophils. Nature 249 (457): 581-582.
2. Singh P, Singh IN, Mondal SC, et al. (2013) Platelet-activating factor (PAF)-antagonists of natural origin. Fitoterapia 84: 180-201.
3. Stafforini DM, McIntyre TM, Zimmerman GA, et al. (2003) Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. Critical Reviews in Clinical Laboratory Sciences 40: 643-672.
4. Chao W, Olson MS, (1993) Platelet-activating factor: Receptors and signal transduction. Biochemical Journal 292: 617.
5. Nakamura M, Honda Z, Izumi T, (1991) Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. Journal of Biological Chemistry 266: 20400.
6. Montrucchio G, Alloatti G, Camussi G, (2000) Role of platelet-activating factor in cardiovascular pathophysiology. Physiological Reviews 80: 1669-1699.
7. Dziedziczko A, Pałgan K, (2004) Eosinophil apoptosis and asthma. Polski Merkuriusz Lekarski 17 (97): 73-75.
8. Dyer KD, Percopo CM, Xie Z, et al. (2010) Mouse and human eosinophils degranulate in response to PAF and lysoPAF via a PAF-receptor independent mechanism: Evidence for a novel receptor. Journal of Immunology 184 (11): 6327-6334.
9. Kato M, Kimura H, Motegi Y, et al. (2002) Platelet-activating factor activates two distinct effector pathways in human eosinophils. Journal of Immunology 169 (9): 5252-5259.
10. Kato M, Yamaguchi T, Tachibana A, et al. (2005) An atypical protein kinase C, PKC, regulates human eosinophil effector functions. Immunology 116 (2): 193-202.
11. Pałgan K, Kołakowska J, Zbikowska-Gotz M, (2000) The role of mast cells in inflammatory reactions. Pneumonologia i Alergologia Polska 68: 603-609.
12. Nilsson G, Schwartz LB, (1995) Mast cell heterogeneity: structure and mediators. In: Busse WW, Holgate ST, editors. Asthma and Rhinitis. Boston: Blackwell Science, p. 195.
13. Kajiwara N, Sasaki T, Bradding P, et al. (2010) Activation of human mast cells through the platelet-activating factor receptor. Journal of Allergy and Clinical Immunology 125 (5): 1137-1145.e6.
14. Petersen LJ, Church MK, Skov PS, (1997) Platelet-activating factor induces histamine release from human skin mast cells in vivo, which is reduced by local nerve blockade. Journal of Allergy and Clinical Immunology 99 (5): 640-647.
15. Triggiani M, Patella V, Staiano RI, et al. (2008) Allergy and the cardiovascular system. Clinical and Experimental Immunology 153 Suppl 1: 7-11.
16. Kruszewski J, Błaowski N, Grzelewska-Rzymowska I, et al. (2009) Anaphylaxis. The stance of the expert panel of the Polish Society of Allergology. In: Kruszewski J, (ed.) Medycyna Praktyczna. Krakow.
17. Vadas P, Gold M, Perelman B, et al. (2008) Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. New England Journal of Medicine 358 (1): 28-35.
18. Zheng GH, Xiong SQ, Mei LJ, et al. (2012) Elevated plasma platelet activating factor, platelet activating factor acetylhydrolase levels and risk of coronary heart disease or blood stasis syndrome of coronary heart disease in Chinese: A case control study. Inflammation 35: 1419-1428.
19. Srinivasan P, Bahnson BJ, (2010) Molecular model of plasma PAF acetylhydrolase-lipoprotein association: Insights from the structure. Pharmaceuticals (Basel) 3 (3): 541-557.
20. Guerra R, Zhao B, Mooser V, et al. (1997) Determinants of plasma platelet activating factor acetylhydrolase: Heritability and relationship to plasma lipoproteins. Journal of Lipid Research 38: 2281-2288.
21. Finkelman FD, Rothenberg ME, Brandt EB, et al. (2005) Molecular mechanisms of anaphylaxis: Lessons from studies with murine models. Journal of Allergy and Clinical Immunology 115: 449-457.
22. Vadas P, Perelman B, Liss G, (2013) Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis. Journal of Allergy and Clinical Immunology 131 (1): 144-149.
23. Järvinen KM, Celestin J, (2014) Anaphylaxis avoidance and management: Educating patients and their caregivers. Journal of Asthma and Allergy 7: 95-104.
24. Banerji A, Rudders SA, Corel B, et al. (2010) Repeat epinephrine treatments for food-related allergic reactions that present to the emergency department. Allergy and Asthma Proceedings 31 (4): 308-316.
25. Vadas P, Perelman B, (2012) Effect of epinephrine on platelet-activating factor-stimulated human vascular smooth muscle cells. Journal of Allergy and Clinical Immunology 129: 1329-1333.
26. Cuss FM, Dixon CMS, Barnes PJ, (1986) Effects of inhaled platelet-activating factor on pulmonary function and bronchial responsiveness in man. Lancet 8500: 189-191.
27. Pretolani M, Vargaftig BB, (1993) From lung hypersensitivity to bronchial hyperreactivity. What can we learn from studies on animal models? Biochemical Pharmacology 45 (4): 791-800.
28. Howard KM, (2009) Differential expression of platelet-activating factor acetylhydrolase in lung macrophages. American Journal of Physiology Lung Cellular and Molecular Physiology 297 (6): L1141-L1150.
29. Bae R, Arteaga A, Raj JU, et al. (2012) Albuterol isomers modulate platelet-activating factor synthesis and receptor signaling in human bronchial smooth muscle cells. International Archives of Allergy and Immunology 158 (1): 18-26.
30. Kasperska-Zajac A, Brzoza Z, Rogala B, (2008) Platelet-activating factor (PAF): A review of its role in asthma and clinical efficacy of PAF antagonists in the disease therapy. Recent Patents on Inflammation & Allergy Drug Discovery 2 (1): 72-76.
31. Grotta MB, Squebola-Cola DM, Toro AA, et al. (2013) Obesity increases eosinophil activity in asthmatic children and adolescents. BMC Pulmonary Medicine 13 (1): 39-46.
32. Jain S, (2014) Pathogenesis of chronic urticaria: An overview. Dermatology Research and Practice 2014: 674709.
33. Aktar S, Akdeniz N, Ozkol HU, et al. (2015) The relation of autologous serum and plasma skin test results with urticarial activity score, sex and age in patients with chronic urticaria. Postepy Dermatologii i Alergologii 32 (3): 173-178.
34. Spickett G, (2014) Urticaria and angioedema. Journal of the Royal College of Physicians of Edinburgh 44 (1): 50-54.
35. Bossi F, Frossi B, Radillo O, et al. (2011) Mast cells are critically involved in serum-mediated vascular leakage in chronic urticaria beyond high-affinity IgE receptor stimulation. Allergy 66 (12): 1538-1545.
36. Mullol J, Bousquet J, Bachert C, et al. (2008) Rupatadine in allergic rhinitis and chronic urticaria. Allergy 63 Suppl 87: 5-28.
37. Nettis E, Delle Donne P, Di Leo E, et al. (2013) Rupatadine for the treatment of urticaria. Expert Opinion on Pharmacotherapy 14 (13): 1807-1813.
38. Rihoux JP, Fadel R, Juhlin L, (1991) Platelet-activating factor-induced immediate and late cutaneous reactions. International Archives of Allergy and Applied Immunology 94: 299-300.
39. Durack A, Matin RN, (2014) Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: A critical appraisal. British Journal of Dermatology 171 (1): 10-13.